Axio Biosolutions Pvt Ltd of Ahmedabad at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option
Manufacturers

Axio Biosolutions Pvt Ltd

Plot No.18, Gujarat Pharma Techno Park, Sari- Matoda, TA: Sanand, 382220 Ahmedabad
India

This company is co-exhibitor of
India Trade Promotion Organisation

Hall map

MEDICA 2019 hall map (Hall 6): stand C63

Fairground map

MEDICA 2019 fairground map: Hall 6

Contact

Yashas Chandra

Phone
+919724099723

Email
int.sales@axiobio.com

Our range of products

Product categories

  • 05  Commodities and Consumer Goods
  • 05.15  Wound care equipment
  • 05.15.08  Instant wound dressings

Our products

Product category: Instant wound dressings

Axiostat Chitosan Haemostat

Axiostat® is a FDA,CE Certified sterile, single use haemostatic dressing made up of 100% Chitosan intended to be used for temporary control of bleeding wounds and can stop  haemorrhage from actively bleeding vessels within minutes. Axiostat® is ready to use and can be cut to suit different wound sizes and stops moderate to severe bleeding due to cuts, abrasions, lacerations, venous or arterial bleeding in various complex situations arising in Cathlabs and Operating Theatres to Battlefield.

More Less

Product category: Instant wound dressings

Maxiocel Chitosan Wound dressing

MaxioCel is a non woven microfibre dressing made up of 100% chitosan. Maxiocel is a highly absorbent antimicrobial wound dressing, designed to heal patients suffering from chronic wounds by effectively managing exudates, pain relief and scar improvement. Maxiocel can be used for moderate to heavily exudating wounds of varied depth, shape and size.

More Less

Company news

Date

Topic

Download

Apr 24, 2019

Axio Biosolutions attains world class position

India’s leading innovative medtech company, Axio Biosolutions, recently expanded its state-of-the-art manufacturing facility at Gujarat Pharma Techno Park in Ahmedabad, India to over a million units annually and has become the largest chitosan medical sponge manufacturer globally.

As the first-ever Indian company to design and launch a novel haemostat for moderate to severe bleeding, Axio Biosolutions has been consistently disrupting the wound care management industry. Its manufacturing facility is ISO 13485 certified and GMP approved, with an ISO 7, Class 10000 cleanroom. Now, with the cutting-edge factory that is 75 per cent automated, boosting the annual capacity to over a million units, the company is all set to conquer new frontiers.

Commenting on the latest development, Gourav Maheshwari, Director – Finance & Operations, said, “Our products are proudly made in India for the global market. With this expansion along with USFDA clearance for our products we are closer to realising our aspirations to become a global medtech company from India. We have created more than 100 jobs for local community with a significant contribution of women staff, we believe this facility will set a benchmark for medtech manufacturing in India.“

Axio Biosolutions is a medtech company with focus on biomaterials. The company offers a complete range of innovative products spanning pre-hospital, intra-operative and post-operative clinical needs. Its first product range Axiostat is a USFDA and CE approved product that stops bleeding instantly. Earlier this year, the company launched MaxioCel, a next-generation, chitosan-based advanced wound care dressing that provides comfort and faster healing to patients suffering from chronic wounds.

Axio Biosolutions recently announced its top-notch Scientific Advisory Board, comprising Dr Shiladitya Sengupta, Assistant Professor of Medicine at Harvard Medical School, as Chairman and Dr S V Mahadevan, Professor of Emergency Medicine at Stanford University, as member.

Last year, the company raised $7.4 million in a Series B funding round led by Ratan Tata’s UC- RNT, along with existing investors Accel Partners and IDG Ventures India.

Headquartered in Cambridge, Axio Biosolutions has its corporate office in Bengaluru. The company has strong R&D with multiple patents to its credit.

More Less

About us

Company details

Axio is a medtech company specialized on biomaterials and develops products for haemostasis, wound care and drug delivery.We specialise in manufacturing of Chitosan Haemostats and Wound dressings in ISO GMP Certified world class facility.

More Less